Credit Suisse’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.23B | Buy |
1,584,543
+68,198
| +4% | +$48.5M | 1.18% | 11 |
|
|
2023
Q4 | $884M | Sell |
1,516,345
-130,089
| -8% | -$75.9M | 0.85% | 14 |
|
|
2023
Q3 | $884M | Buy |
1,646,434
+15,107
| +0.9% | +$7.78M | 0.9% | 14 |
|
|
2023
Q2 | $765M | Sell |
1,631,327
-44,663
| -3% | -$18.7M | 0.76% | 18 |
|
|
2023
Q1 | $576M | Buy |
1,675,990
+50,717
| +3% | +$17.1M | 0.58% | 26 |
|
|
2022
Q4 | $595M | Buy |
1,625,273
+105,337
| +7% | +$37.3M | 0.63% | 21 |
|
|
2022
Q3 | $491M | Buy |
1,519,936
+31,367
| +2% | +$9.94M | 0.55% | 24 |
|
|
2022
Q2 | $483M | Buy |
1,488,569
+17,201
| +1% | +$5.16M | 0.5% | 29 |
|
|
2022
Q1 | $421M | Buy |
1,471,368
+44,471
| +3% | +$11.4M | 0.36% | 46 |
|
|
2021
Q4 | $394M | Sell |
1,426,897
-93,240
| -6% | -$23.6M | 0.21% | 75 |
|
|
2021
Q3 | $351M | Buy |
1,520,137
+93,845
| +7% | +$23.2M | 0.19% | 83 |
|
|
2021
Q2 | $327M | Buy |
1,426,292
+22,769
| +2% | +$4.57M | 0.17% | 94 |
|
|
2021
Q1 | $262M | Buy |
1,403,523
+175,323
| +14% | +$34.3M | 0.13% | 140 |
|
|
2020
Q4 | $207M | Sell |
1,228,200
-56,059
| -4% | -$8.37M | 0.1% | 207 |
|
|
2020
Q3 | $190M | Sell |
1,284,259
-120,389
| -9% | -$18.6M | 0.12% | 177 |
|
|
2020
Q2 | $231M | Sell |
1,404,648
-239,055
| -15% | -$36.7M | 0.17% | 115 |
|
|
2020
Q1 | $228M | Sell |
1,643,703
-1,261,139
| -43% | -$173M | 0.2% | 98 |
|
|
2019
Q4 | $382M | Buy |
2,904,842
+624,475
| +27% | +$72.4M | 0.28% | 53 |
|
|
2019
Q3 | $255M | Sell |
2,280,367
-109,407
| -5% | -$12.2M | 0.22% | 74 |
|
|
2019
Q2 | $265M | Sell |
2,389,774
-45,791
| -2% | -$5.39M | 0.23% | 70 |
|
|
2019
Q1 | $316M | Buy |
2,435,565
+964,587
| +66% | +$117M | 0.29% | 48 |
|
|
2018
Q4 | $170M | Sell |
1,470,978
-344,507
| -19% | -$38.5M | 0.18% | 98 |
|
|
2018
Q3 | $195M | Buy |
1,815,485
+394,617
| +28% | +$39.5M | 0.17% | 93 |
|
|
2018
Q2 | $121M | Sell |
1,420,868
-105,955
| -7% | -$8.7M | 0.12% | 150 |
|
|
2018
Q1 | $118M | Sell |
1,526,823
-82,997
| -5% | -$6.68M | 0.11% | 177 |
|
|
2017
Q4 | $136M | Sell |
1,609,820
-58,071
| -3% | -$4.94M | 0.12% | 144 |
|
|
2017
Q3 | $143M | Sell |
1,667,891
-32,606
| -2% | -$2.67M | 0.14% | 140 |
|
|
2017
Q2 | $140M | Sell |
1,700,497
-143,473
| -8% | -$11.7M | 0.14% | 133 |
|
|
2017
Q1 | $155M | Sell |
1,843,970
-45,936
| -2% | -$3.68M | 0.14% | 134 |
|
|
2016
Q4 | $139M | Sell |
1,889,906
-338,423
| -15% | -$25.2M | 0.14% | 141 |
|
|
2016
Q3 | $179M | Buy |
2,228,329
+325,505
| +17% | +$26.1M | 0.17% | 101 |
|
|
2016
Q2 | $150M | Buy |
1,902,824
+103,667
| +6% | +$7.8M | 0.17% | 114 |
|
|
2016
Q1 | $130M | Sell |
1,799,157
-46,342
| -3% | -$3.51M | 0.16% | 125 |
|
|
2015
Q4 | $156M | Sell |
1,845,499
-1,026,419
| -36% | -$85.2M | 0.18% | 115 |
|
|
2015
Q3 | $240M | Sell |
2,871,918
-294,287
| -9% | -$24.8M | 0.29% | 63 |
|
|
2015
Q2 | $264M | Sell |
3,166,205
-348,897
| -10% | -$26.6M | 0.26% | 73 |
|
|
2015
Q1 | $255M | Sell |
3,515,102
-466,934
| -12% | -$33.2M | 0.26% | 75 |
|
|
2014
Q4 | $275M | Sell |
3,982,036
-138,248
| -3% | -$9.33M | 0.24% | 78 |
|
|
2014
Q3 | $267M | Sell |
4,120,284
-585,357
| -12% | -$37.1M | 0.22% | 80 |
|
|
2014
Q2 | $293M | Sell |
4,705,641
-439,796
| -9% | -$26.2M | 0.24% | 73 |
|
|
2014
Q1 | $303M | Buy |
5,145,437
+1,358,747
| +36% | +$75.8M | 0.3% | 57 |
|
|
2013
Q4 | $193M | Buy |
3,786,690
+740,493
| +24% | +$37.1M | 0.18% | 98 |
|
|
2013
Q3 | $153M | Sell |
3,046,197
-932,767
| -23% | -$48.8M | 0.15% | 116 |
|
|
2013
Q2 | $195M | Buy |
+3,978,964
| New | +$217M | 0.2% | 80 |
|
Other funds holding LLY
Credit Suisse's LLY Position: Q1 2024 in Review
Credit Suisse increased its Eli Lilly (LLY) stake by 4.5% in Q1 2024, buying an estimated $48.5M and bringing the position to 1,584,543 shares worth $1.23B. The position accounts for 1.18% of the portfolio, ranked #11.
Credit Suisse first reported a position in LLY in Q2 2013 and has held it in 44 quarters since. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.
- Credit Suisse held 1,584,543 shares of Eli Lilly worth $1.23B as of Q1 2024.
- Credit Suisse bought 68,198 Eli Lilly shares in Q1 2024, an estimated $48.5M.
- Eli Lilly made up 1.18% of Credit Suisse's portfolio in Q1 2024, its #11 holding.
- Credit Suisse first reported a position in Eli Lilly in Q2 2013 and has held it in 44 quarters since.
- 3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.